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Background: The possible association between metabolic syndrome (MS) and bone mineral density (BMD) has
been highlighted recently. However, the exact effects of MS on calcaneal quantitative ultrasound (QUS) parameters
remains uncertain. The aim of this study was to assess the impact of MS states, different componets of MS, as well
as the number of MS componets on QUS.
Methods: A total of 7489 Chinese adults aged 40 years or older in Nanjing were enrolled in this cross-sectional
study. MS was defined according to recommendations generated by the International Diabetes Federation (IDF) in
2005. QUS was measured for each participant.
Results: The prevalence of MS was 34.6% in men and 42.8% in women (over 40 years old). In postmenopausal
women with MS, 25-hydroxyvitamin D[25(OH)D], age adjusted quantitative ultrasound index (QUI) and broadband
ultrasound attenuation (BUA) were all lower than those without (p < 0.001, p = 0.023, p = 0.021, respectively), the
difference of QUI and BUA disappeared after adjustment for body mass index (BMI) and waist circumference (WC).
In stepwise analysis, BMI, WC, high density lipoprotein cholesterol (HDL-C) and fasting plasma glucose (FPG) were
related to QUS (p < 0.05). The number of MS components had no influence on QUS. Fragile fracture incidence was
higher in women with MS (6.8% VS. 5.3%, P = 0.034).
Conclusion: Chinese postmenopausal women with MS have worse BMD measured by QUS and more chances to
develop osteoporotic fractures than the controls, which partially due to central obesity as well as vitamin D
deficiency. People having less central obesity, higher FPG or HDL-C are less likely to have bone mineral loss.
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Metabolic syndrome is characterized by a constellation of
cardiovascular risk factors that includes high abdominal
adiposity, blood pressure, glucose and triglycerides (TG)
and low HDL-C levels [1]. It has become increasingly
common worldwide, especially in old population, and it is
considered to be highly associated with increased risk of
developing cardiovascular disease and type 2 diabetes* Correspondence: hewei1007@sina.cn; yangt@njmu.edu.cn
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reproduction in any medium, provided the ormellitus (T2DM) [2]. The prevalence of MS in asymptom-
atic US adults 40 years and older was 22.8% [3]. The preva-
lence of MS in Chinese older than 20 years was 12%-21%
diagnosing by National Education Cholesterol Program
Adult Treatment Panel-III (NECP-ATPIII) criterion [4].
Osteoporosis is another common metabolic bone dis-
ease characterized by prominent skeletal fragility (due to
reduction in both bone quantity and quality), leading to
an increased risk of developing spontaneous fractures and
chronic pain [5]. The prevalence of osteoporosis in old age
groups is very high. A nationwide epidemiological survey
from 1997 to 1999 showed that the prevalence of. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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women and 11.5% for men, BMD of vertebra and femur
neck measured by dual energy X-ray absorptiometry
(DXA) [6].
Recently, more evidence has accumulated for a possible
link between MS and osteoporosis, but the results from dif-
ferent studies are inconsistent. Some studies suggested that
MS might be a risk factor for osteoporosis [7,8], while
others concluded that MS can protect against osteoporotic
fractures [9,10]. Most of the previous studies about the rela-
tionship are based on the BMD derived by DXA. QUS, an-
other method to evaluate BMD, can reflect both bone mass
and bone quality [11]. According to a study in Germany,
QUS and DXA are equally strongly associated with risk fac-
tors for osteoporosis [12]. On the other hand, although
both DXA and QUS are good predictors for osteoporotic
fractures, they still differ in several aspects. Compared to
DXA, QUS is more convenient, easily available and lack of
ionizing radiation, so it’s a simple and inexpensive method
for screening osteoporosis, especially in population-based
studies. Until now, only few surveys have addressed the as-
sociation between MS and QUS and the results are contro-
versial [13-16]. Whether MS has a strong impact on QUS,
whether different components of MS contribute diversely
to the QUS are worth further investigation.
In the present cross-sectional study, we had the follow-
ing specific aims: 1) to compare the QUS parameters in
individuals with and without MS in Chinese population; 2)
to determine the association of the QUS parameters with
the components of MS respectively, as well as with the
number of MS components; 3) to study the relationship




People older than 40 years old who lived in Gulou, Nanjing,
China were invited to participate in this community-based
project. A total of 9982 people were recruited, from June to
December 2011. The study was approved by the ethics
committee of The First Affiliated Hospital with Nanjing
Medical University. Totally 2493 individuals who met the
following criteria were excluded: 1) individuals had not fin-
ish the questionnaire or examination; 2) those taking cal-
cium, vitamin D or other medication for osteoporosis; 3)
having received sexual hormone replacement therapy or
other medications affecting QUS, such as glucocorticoster-
oid; 4) has a history of hematologic disease, rheumatoid
arthritis or systemic lupus erythematosus, etc. Finally, 7489
individuals were involved in our study.
A standard questionnaire was used for collection of all
the information about health states, medications, and life-
style. The smoking or alcohol consumption habit was clas-
sified as never, current (smoking or consuming alcoholregularly in the past 6 months), or ever (cessation of
smoking or alcohol consumption for more than 6 months).
The type, amount, and frequency of alcohol consumption
were also recorded.
Physical examinations were performed by profes-
sional physicians. The BMI was calculated as body
weight (kg) divided by squared body height (m2). WC
was measured in centimeters with a flexible tape all
around the body at the level of navel. Blood pressure
was measured with a sphygmomanometer and was
taken as the mean of 3 consecutive measurements after
at least 5 minutes of rest.
Laboratory measurements
After a requested 12-hour fast, morning blood samples of
every participants were obtained from an antecubital vein
for measurements of FPG, serum HDL-C, low density lipo-
protein cholesterol (LDL-C), TG and total cholesterol (TC).
Plasma glucose was measured by hexokinase method.
HDL-C, LDL-C, TG and TC were quantified using chemi-
luminescence assays on the auto-analyzer (Modular E170;
Roche). Serum 25(OH)D was assessed by enzyme immuno-
assay (IDS, UK).
MS definition
We used recommendations generated by IDF in 2005 for
MS definition. Subjects were considered as MS if they had
central obesity (WC ≥ 90 cm in Chinese men and ≥80 cm
in Chinese women, or BMI over 30 kg/m2) plus at least
two abnormalities from the following four compo-
nents: TG > 1.7 mmol/L or receiving specific treatment
for this lipid abnormality; HDL-C < 1.03 mmol/L in
men and <1.29 mmol/L in women or receiving specific
lipid-lowing therapy; SBP ≥ 130 mmHg or DBP ≥ 85 mmHg
or having treatment of previously diagnosed hypertension;
FPG ≥ 5.6 mmol/L or previous history of type 2 diabetes.
Calcaneal QUS assessment
Calcaneal QUS was measured at the participant’s domin-
ant foot by experienced operators with the Sahara Clinical
Sonometer (Hologic, Bedford, MA, USA). BUA (dB/MHz)
and speed of sound (SOS) (m/s) were recorded and the
QUI was calculated from BUA and SOS. Daily calibration
was performed before measurement according to the
manufacturer’s recommendations.Identification of fragile fractures
According to the questionnaire, all fractures were self-
reported and collected. Fractures were classified as either
minor (e.g. fall from standing height or less) or sever
trauma (e.g. resulting from a harder fall, a car accident or
other severe trauma). Fragile fractures were defined as frac-
tures that occur with a minor trauma after 25 years of age.
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Analysis was performed using SPSS 17.0 for Windows
(Chicago, IL, USA). Student’s t test and Х2 test were used
to compare the difference between two groups for con-
tinuous variables and categorical variables, respectively.
To compare the QUS parameters adjusting for covariates
including age, BMI, WC, daily exercise, current smoking
and current alcohol intake, covariance analysis was per-
formed. The relationship between QUS parameters with
the components of MS was determined using stepwise
multiple linear regressions. Spearman and partial correl-
ation was also used to analysis the connection between
number of MS components and QUS parameters. Logistic
regression models were constructed to analyse the associ-
ation between osteoporosis fractures and MS states, as
well as QUS parameters.
Results
Baseline characteristics and laboratory parameters
Finally, a total of 7489 individuals were eligible for ana-
lysis in this study, of them there were 2814 males and
4675 females, including 983 premenopausal women and
3692 postmenopausal women. The prevalence of MS
was 34.6% in men and 42.8% in women. Table 1 shows the
baseline characteristics of the participants, grouped by sex,
menstrual states and MS states. Participants with MS had
higher weight, BMI, WC, TG and lower HDL-C compared
with those without MS. However, regarding regularTable 1 Baseline characteristics of the participants, grouped b
Males (n = 2814)
MS Y (n = 973) N (n = 1841) Y
Age (yrs) 59.4 ± 9.2 58.9 ± 9.1 47
Ht (cm) 169.1 ± 5.9*** 167.4 ± 6.2 1
Wt (kg) 77.4 ± 8.2*** 65.8 ± 8.4 67
BMI (kg/m2) 27.1 ± 2.4*** 23.5 ± 2.5 26
WC (cm) 95.8 ± 5.3*** 84.0 ± 6.9 87
HDL-C (mmol/L) 1.08 ± 0.25*** 1.25 ± 0.31 1.1
LDL-C (mmol/L) 2.71 ± 0.76 2.72 ± 0.74 2
TG (mmol/L) 2.13 ± 1.50*** 1.41 ± 0.99 2.0
TC (mmol/L) 4.66 ± 1.01 4.62 ± 0.94 4
FPG (mmol/L) 6.77 ± 1.84*** 6.16 ± 1.73 6.3
SBP (mmHg) 138.04 ± 16.01*** 129.23 ± 16.45 131.
DBP (mmHg) 83.61 ± 10.09*** 78.80 ± 10.35 82.3
Regular exercise (%) 41.7 45.3
Current smoking (%) 23.3 22.3
Current alcohol intake (%) 15.3 13.8
Continuous data are expressed as means ± SD, category data as indicated. MS meta
circumference; HDL-C high density lipoprotein cholesterol; LDL-C low density lipopr
glucose; SBP systolic blood pressure; DBP diastolic blood pressure.
***p < 0.001 compared with subjects without MS.exercise, current smoking and current alcohol consump-
tion, no difference was found between groups with or with-
out MS.
QUS assessment
The results of covariates with adjusted mean QUS pa-
rameters in participants with and without MS are shown
in Table 2. The associations between QUS parameters
and MS were not significant either before or after ad-
justed by different models in males as well as in premen-
opausal women whereas in postmenopausal women with
MS the BMD was found lower than those without before
or after age adjustment. SOS in postmenopausal women
with MS was significantly lower than in those without.
However, after adjusted for age the difference regarding
SOS disappeared. No differences regarding BUA, QUI or
T-score were found before any adjustment between the
groups in postmenopausal women, while the associa-
tions were significant after age adjustment.
Stepwise multiple linear regression analysis with QUS pa-
rameters as the dependent variable and age, BMI, compo-
nents of MS, alcohol intake, smoking, and regular exercise
as independent variables was performed in each group. As
shown in Table 3, in males, BMI was positively associated
while WC was negatively associated with all QUS parame-
ters. Positive relationship was also observed between FPG
and SOS, QUI. In premenopausal women, only HDL-C
had positive association with all QUS parameters, noy sex, menstrual states and MS states
Females (n = 4675)
Premenopausal (n = 983) Postmenopausal (n = 3692)
(n = 237) N (n = 746) Y (n = 1763) N (n = 1929)
.7 ± 4.0*** 46.0 ± 3.8 61.2 ± 7.5*** 57.7 ± 7.6
59.1 ± 5.3 158.5 ± 5.2 156.5 ± 5.6 156.6 ± 5.4
.3 ± 8.8*** 57.6 ± 7.2 64.3 ± 8.4*** 56.2 ± 7.5
.6 ± 3.0*** 22.9 ± 2.6 26.3 ± 3.0*** 22.9 ± 2.8
.7 ± 6.6*** 76.8 ± 7.1 89.2 ± 7.2*** 78.4 ± 8.1
6 ± 0.24*** 1.39 ± 0.32 1.24 ± 0.28*** 1.44 ± 0.37
.66 ± 0.71 2.62 ± 0.72 2.92 ± 0.82 2.93 ± 0.79
9 ± 1.41*** 1.09 ± 0.64 2.01 ± 1.28*** 1.27 ± 0.76
.66 ± 0.94 4.60 ± 0.92 5.07 ± 1.08 5.10 ± 1.02
0 ± 1.99*** 5.39 ± 1.02 6.58 ± 1.80*** 5.63 ± 1.14
17 ± 18.96*** 117.53 ± 13.21 137.96 ± 16.42*** 124.12 ± 16.13
1 ± 10.82*** 73.88 ± 9.54 79.46 ± 9.75*** 74.39 ± 9.64
40.9 40.2 41.9 39.6
7.2 7.5 7.1 6.6
3.0 4.7 4.5 3.7
bolic syndrome; Ht height; Wt weight; BMI body max index; WC waist
otein cholesterol; TG triglyceride; TC total cholesterol; FPG fasting plasma
Table 2 QUS parameters grouped by sex, menstrual states and MS states
With MS Without MS P value
Unadjusted Model1 Model2 Model3
Males
BUA (dB/MHz) 75.92 ± 15.94 75.75 ± 16.73 0.788 0.831 0.957 0.962
SOS (m/s) 1539.56 ± 28.34 1540.89 ± 29.40 0.248 0.245 0.269 0.233
QUI/sti 91.37 ± 17.44 91.75 ± 18.47 0.593 0.579 0.559 0.492
BMD (g/cm2) 0.501 ± 0.111 0.503 ± 0.117 0.627 0.613 0.317 0.276
T-score −0.953 ± 1.270 −0.926 ± 1.178 0.569 0.551 0.523 0.447
Premenopausal women
BUA (dB/MHz) 77.52 ± 15.50 79.35 ± 15.26 0.110 0.088 0.355 0.322
SOS (m/s) 1547.23 ± 26.37 1549.81 ± 28.55 0.198 0.154 0.610 0.585
QUI/sti 95.15 ± 16.57 96.86 ± 17.48 0.184 0.143 0.476 0.446
BMD (g/cm2) 0.526 ± 0.104 0.537 ± 0.109 0.163 0.117 0.485 0.453
T-score −0.475 ± 1.062 −0.353 ± 1.095 0.133 0.095 0.392 0.364
Postmenopausal women
BUA (dB/MHz) 70.55 ± 16.88 71.38 ± 16.85 0.137 0.021* 0.851 0.825
SOS (m/s) 1531.68 ± 27.98 1533.68 ± 27.93 0.030* 0.081 0.295 0.299
QUI/sti 85.95 ± 17.74 87.00 ± 17.60 0.072 0.023* 0.474 0.489
BMD (g/cm2) 0.467 ± 0.113 0.474 ± 0.111 0.043* 0.041* 0.585 0.599
T-score −1.030 ± 1.437 −0.987 ± 1.116 0.301 0.022* 0.370 0.385
Model 1 is adjusted by age, Model 2 is adjusted by age + BMI + WC, Model 3 is adjusted by age + BMI + WC + daily exercise + current smoking + current
alcohol consumption. BMI body max index; WC waist circumference; BUA broadband ultrasound attenuation; SOS speed of sound; QUI quantitative ultrasound
index; BMD bone mineral density.
*P < 0.05.
Table 3 Stepwise multiple linear regression analyses with
QUS parameters as the dependent variable and age, BMI,
components of MS (WC, HDL-C, TG, FPG, SBP, DBP), alcohol




BMI 0.115*** 0.150*** 0.138***
WC −0.093** −0.192*** −0.153***
FPG - 0.054** 0.048*
Premenopausal women
HDL-C 0.123*** 0.100** 0.111***
Postmenopausal women
Age −0.276*** −0.290*** −0.292***
BMI 0.085*** 0.116*** 0.109***
WC - −0.094*** −0.054*
HDL-C 0.065*** 0.034* 0.058**
TG - - 0.036*
FPG 0.037*** 0.053** 0.050**
SBP - 0.047** -
BMI body max index; WC waist circumference; HDL-C high density lipoprotein
cholesterol; TG triglyceride; FPG fasting plasma glucose; SBP systolic blood
pressure; BUA broadband ultrasound attenuation; SOS speed of sound; QUI
quantitative ultrasound index.
*P < 0.05; **P < 0.01; ***P < 0.001.
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of MS. In postmenopausal women, we found age related
negatively to all QUS parameters and BMI, HDL-C, FPG
related positively to all QUS parameters. There were nega-
tive associations between WC and SOS as well as QUI.
Positive relationship was also found between SBP and SOS,
and the same between TG and QUI.
Besides, the number of MS components was not sta-
tistically associated with QUS parameters in both gen-
ders before or after age adjustment (data not shown).
Fragile fractures
Of all 7489 participants, there were 9.59% (men) and 9.65%
(women) subjects had fractures. Osteoporotic fractures
were found in 3.84% men and in 5.95% women, respect-
ively. Among the people who had MS, 6.8% women and
3.7% men have suffered from fragile fractures. Women with
MS got higher incidence of fragile fractures than those
without (6.8% VS. 5.3%, P = 0.034), while no impact of MS
states on fragile fractures was found in male.
25(OH)D levels
In postmenopausal women, we randomly chose 1739
subjects who participated the project from September to
November to have their serum 25(OH)D measured. We
found that postmenopausal women with MS had lower
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Lvs.44.95 ± 14.63 nmol/L, P < 0.001), and the difference
remained even after age and BMI adjustment. In women
with vitamin D deficiency [25(OH)D < 50 nmol/L], the
prevalence of MS was 54%, which was significantly
higher than those without vitamin D deficiency (47.8%).
Discussion
We have studied the relationship between MS and param-
eters of QUS in a relatively large middle-aged and elderly
Chinese population. For the first time, the impact of the
MS on osteoporotic fractures in this population was inves-
tigated. On one hand, QUS was chosen as an evaluation of
bone characteristics because its convenience compared
with DXA, on the other hand, MS represents a major
health problem nowadays. More information provided by
our study will help to understand the pathogenesis of
metabolic bone disease further.
In our study, 39.7% participants were diagnosed with
MS according to the IDF criteria, which was a little higher
than the results from previous studies in China, mainly
because our study is a community based study instead of
epidemiological investigation and we did not standardize
age and gender, and the mean age of subjects in our study
is relative older. Besides, different diagnostic criteria may
also lead to the difference.
To our knowledge, this is the first study showing an in-
verse association between MS and bone states assessed by
QUS. For previous studies, the relationship between MS
and QUS is not confirmed. Two studies in Spain found
positive associations between MS and QUS [13,15], while a
study in Taiwan [14] found no association between bone
mineral loss and the MS in both genders. This is not sur-
prising, for there is also a debate about the correlation be-
tween MS and BMD measured by DXA. This inconsistency
may because of different population studied and different
diagnostic standard used for MS. As far as we know, few
studies used the same criteria as ours for investigating the
impact of MS on QUS. Two reports which also choose IDF
criteria for MS found different association between MS and
BMD assessed by DXA. The study in Korean showed a
negative association [17], whereas a Bulgaria study [18]
confirmed the trend for higher BMD in men with MS.
Interestingly, the relationship between MS and QUS in
this study differs between genders and between meno-
pause statues. We did not found any relationship between
MS and QUS in men and premenopausal women, which
coincides with the Camargo cohort study [13] and the
Taiwan study [14] about QUS, and also in agreement with
previous studies with DXA [17]. A study in an older popu-
lation even found that QUI was significantly lower in men
with MS but significantly higher in women with MS when
compared to their controls [16]. All these results suggest
that bone metabolism changes in MS may be affected by alot of factors coming from gender and menopause states
which means different physiological situations.
We also investigated how different components of MS
affect QUS in this study. BMI and WC were related to
QUS parameters in men and postmenopausal women,
people had higher QUS values with higher BMI and
lower WC. The Camargo cohort study about QUS [13]
and the studies by Cvijetic [16] and Kim [17] about
ultrasound bone measurement and DXA, also got the
similar conclusion, respectively. Together with their re-
sults [19,20], we support the idea that the relationship
between obesity and osteoporosis depends on how obes-
ity is defined. If obesity is based on BMI, it might protect
against osteoporosis. However, obesity appears to be a
risk factor for bone loss, if it is defined as central obesity.
It is widely known that visceral fat is responsible for the
storage and mobilization of lipids as well as releasing cy-
tokines such as interleukin-6 (IL-6) and tumor necrosis
factor-alpha (TNF-α), which play a role in bone remod-
eling via their effects on bone formation and resorption
[19]. Thus, it is possible that central obesity in MS pa-
tients be related to bone loss, despite of the protective
effects of weight. The diagnostic criteria for MS from
IDF 2005 define the central obesity as the essential cri-
terion, while some other diagnostic criteria do not ne-
cessarily include central obesity. So the weight of central
obesity on bone metabolism may be bigger in our study
as we use the IDF 2005 MS diagnostic system. This dif-
ference may also explain the disagreement between our
study and others partially.
It is well known that vitamin D deficiency is a major risk
factor of osteoporosis and it has been implicated in associ-
ation with the development of diabetes, hypertension and
obesity recently [21,22]. A five-year follow-up study in
Australia found that lower 25(OH)D level was associated
with increased MS risk [23], Maki et al. [24] found that
greater dietary vitamin D intake was associated with re-
duced prevalence of MS, which was validated by us. Low
25(OH)D levels in MS population may partially explain
why they have lower QUS and higher incidence of fragile
fractures. The causes of why vitamin D deficient are asso-
ciated with MS still need further investigation.
Concerning glucose intolerance, our study shows that im-
paired glucose tolerance seems to increase the QUS param-
eters in men and postmenopausal women. Sauque-Reyna
et al. [25] also found T2DM is an independent protective
factor for osteoporosis, using DXA. Besides, Bulló et al. [15]
showed that individuals with T2DM had a significantly
higher BUA and QUI than their non-diabetic counterparts.
Most researchers agree that T2DM has increased bone
mass but decreased bone quality contributing to increased
risk of fractures [26].
Our results support what were found by Jeon et al. [27]
about HDL-C level and BMD, suggesting a protective
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in women. While Buizert et al. [28] observed inverse asso-
ciation between QUS and HDL-C. We only found TG was
positively associated with QUI in postmenopausal women,
consistent with study in Turkey [29]. Some other studies
suggest a certain relation between LDL-C and QUS which
was not discovered by us.
It is interesting that in our study no obvious relation
was observed between hypertension and QUS parame-
ters, except slightly positive association between SBP
and SOS in postmenopausal women. Till now, studies
[13,14] about QUS and hypertension haven’t reached a
confirmed conclusion.
According to our study, in subjects who had central
obesity, most of them (44.03%) met two rest IDF MS diag-
nostic criteria, followed by 38.58% of those met three rest
criteria, least subjects (17.39%) had all of the disorders. It
was disappointing that the number of MS components
had no impact on QUS parameters, i.e. more abnormal-
ities do not increase the chance of QUS changes. Different
from our results, the number of MS components was
positively associated with BMD measured by DXA in both
genders in previous studies [30,31].
Fragile fractures are the severe consequence of osteopor-
osis, leading to the increase in disability and mortality, as
well as enormous family, social and economic burden. Old
age, smoking, alcoholic drinking, hypertension, diabetes
mellitus, hyperlipidemia, elevated C-reactive protein are all
considered associated with osteoporotic fractures [32,33].
MS contents several factors that may impact on osteopor-
otic fractures. Our results showed that women with MS
were more prone to develop osteoporotic fractures than
those without MS. This phenomena was consist with the
difference of QUS parameters caused by MS state found in
this study, suggesting MS an adverse factor for bone health.
This results also verified indirectly the potency of QUS on
prediction of fractures which has been assessed by Ning
and et al. [34].
The strengths of our study lie in its large-scale and
population-based design, including both Chinese males
and females older than 40 years. Although there are a few
similar studies, they were based either on other race or on
a much smaller population [13,14]. Besides of this, our
study not only analysed the association between MS and
osteoporotic fractures, but also provided useful informa-
tion on the relations between MS and QUS in premeno-
pausal women when others mainly focused on mainly
postmenopausal women or men.
However, several limitations of our study have to be ad-
dressed. First of all, due to the cross-sectional nature of the
present study, we can neither draw any causal inference,
nor extrapolate our results to other population. Further
longitudinal studies are needed to clarify the relationships
between MS and QUS. Secondly, the information onfractures were only collected by questionnaires instead of
source documents and radiological examinations, and the
QUS measurements were taken several months or even
years after the fractures which might differ from the QUS
conditions when the fracture occurred. However, according
to the study by Njeh et al. [35], time elapsed since fracture
is not clinically related to QUS evaluation. Thirdly, we did
not measure the level of estrogen, follicle-stimulating
hormone, total calcium, parathyroid hormone and bone
turnover markers, which might affect QUS evaluation.
However, we have excluded subjects who take calcium,
vitamin D, hormone replacement therapy, etc.Conclusion
Our large scale population-based research is the first to re-
port the association both between MS and QUS and be-
tween MS and osteoporotic fractures in middle-aged and
older Chinese population, especially including pre- and
postmenopausal women, and it’s also the first one to show
that MS has detrimental effect on bone mass by QUS and
osteoporotic fractures in postmenopausal women, and the
effect might be driven by central obesity as well as vitamin
D deficiency, highlighting the importance of screening the
BMD in postmenopausal women with MS and supplying
vitamin D to them. More prospective studies are needed to
clarify the underlying causes of these associations. The ef-
fects and the magnitude of different components of MS on
bone metabolism also need further precise investigation.
Abbreviations
QUS: Quantitative ultrasound; MS: Metabolic syndrome; IDF: International
Diabetes Federation; 25(OH)D: 25-hydroxyvitamin D; QUI: Quantitative
ultrasound index; BUA: Broadband ultrasound attenuation; BMI: Body mass
index; WC: Waist circumference; HDL-C: High density lipoprotein cholesterol;
FPG: Fasting plasma glucose; TG: Triglycerides; T2DM: Type 2 diabetes
mellitus; BMD: bone mineral density; DXA: Dual energy X-ray absorptiometry;
LDL-C: Low density lipoprotein cholesterol; TC: Total cholesterol; SOS: Speed
of sound; Ht: Height; Wt: Weight; SBP: Systolic blood pressure; DBP: Diastolic
blood pressure.Competing interests
All authors of this study reported no conflicts of interests.Authors’ contributions
MS, MC, QF, ZZ, CM, JM and YS carried out the participated in the whole
project. MC and MS drafted the manuscript and performed the statistical
analysis. YD, WT, Xiaoping Huang participated in the design of the study.
WH and TY conceived of the study, and participated in its design and
coordination and helped to draft the manuscript. All authors read and
approved the final manuscript.Acknowledgements
We thank all the participants in this study. We thank Prof. Rongbin Yu from
Nanjing Medical University for statistical instructions. This study was
supported by the grants from the Chinese Society of Endocrinology.
Received: 12 November 2012 Accepted: 11 February 2014
Published: 14 February 2014
Sun et al. BMC Endocrine Disorders 2014, 14:14 Page 7 of 7
http://www.biomedcentral.com/1472-6823/14/14References
1. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR,
Groop L: Cardiovascular morbidity and mortality associated with the
metabolic syndrome. Diabetes Care 2001, 24:683–689.
2. Cho LW: Metabolic syndrome. Singapore Med J 2011, 52:779–785.
3. Sumner AD, Khalil YK, Reed JF III: The relationship of peripheral arterial
disease and metabolic syndrome prevalence in asymptomatic US adults
40 years and older: results from the national health and nutrition
examination survey (1999–2004). J Clin Hypertens 2012, 14:144–148.
4. Jia WP, Xiang KS: Current studies on new parameters of metabolic
syndrome. Zhongguo Yi XueKeXue Yuan XueBao 2006, 28:737–739.
5. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis,
and Therapy: Osteoporosis prevention, diagnosis, and therapy.
JAMA 2001, 285:785–795.
6. Li N, Ou P, Zhu H, Yang D, Zheng P: Prevalence rate of osteoporosis in
the mid-aged and elderly in selected parts of China. Chin Med J 2002,
115:773–775.
7. Hwang DK, Choi HJ: The relationship between low bone mass and
metabolic syndrome in Korean women. Osteoporos Int 2010, 21:425–431.
8. Yaturu S, Humphrey S, Landry C, Jain SK: Decreased bone mineral density
in men with metabolic syndrome alone and with type 2 diabetes.
Med SciMonit 2009, 15:CR5–CR9.
9. Yamaguchi T, Kanazawa I, Yamamoto M, Kurioka S, Yamauchi M, Yano S,
Sugimoto T: Associations between components of the metabolic
syndrome versus bone mineral density and vertebralfractures in patients
with type 2 diabetes. Bone 2009, 45:174–179.
10. Ahmed LA, Schirmer H, Berntsen GK, Fonnebo V, Joakimsen RM: Features of
the metabolic syndrome and the risk of non-vertebral fractures: the
tromso study. Osteoporos Int 2006, 17:426–432.
11. Krieg MA, Barkmann R, Gonnelli S, Stewart A, Bauer DC, Del Rio Barquero L,
Kaufman JJ, Lorenc R, Miller PD, Olszynski WP, Poiana C, Schott AM,
Lewiecki EM, Hans D: Quantitative ultrasound in the management of
osteoporosis: the ISCD official positions. J Clin Densitom 2007, 2008
(11):163–187.
12. Glüer CC, Eastell R, Reid DM, Felsenberg D, Roux C, Barkmann R, Timm W,
Blenk T, Armbrecht G, Stewart A, Clowes J, Thomasius FE, Kolta S:
Association of five quantitative ultrasound devices and bone
densitometry with osteoporotic vertebral fractures in a population-based
sample: the OPUS Study. J Bone Miner Res 2004, 19:782–793.
13. Hernández JL, Olmos JM, de Juan J, Martínez J, Ramos C, Valero C, Nan D,
González-Macías J: Heel quantitative ultrasound parameters in subjects
with the metabolicsyndrome: the camargo cohort study. Maturitas 2011,
69:162–167.
14. Tseng YH, Huang KC, Liu ML, Shu WT, Sheu WH: Association between
metabolic syndrome (MS) and bone mineral loss:a cross-sectional study
in puli township in Taiwan. Arch Gerontol Geriatr 2009, 49:S37–S40.
15. Bulló M, Garcia-Aloy M, Basora J, Covas MI, Salas-Salvado J: Bone quantita-
tive ultrasound measurements in relation to the metabolic syndrome
and type 2 diabetes mellitus in a cohort of elderly subjects at high risk
of cardiovascular disease from the PREDIMED study. J Nutr Health Aging
2011, 15:939–944.
16. Cvijetic S, Pavlovic M, Pasalic D, Dodig S: Ultrasound bone measurement
in an older population with metabolic syndrome. Aging ClinExp Res 2011,
23:29–34.
17. Kim HY, Choe JW, Kim HK, Bae SJ, Kim BJ, Lee SH, Koh JM, Han KO, Park HM,
Kim GS: Negative association between metabolic syndrome and bone
mineral density in Koreans, especially in men. Calcif Tissue Int 2010,
86:350–358.
18. Boyanov M, Bakalov D, Boneva Z: Bone mineral density in men with and
without the metabolic syndrome. Aging Male 2009, 12:62–65.
19. Migliaccio S, Greco EA, Fornari R, Donini LM, Lenzi A: Is obesity in women
protective against osteoporosis? Diabetes Metab Syndr Obes 2011, 4:273–282.
20. Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, Deng HW:
Correlation of obesity and osteoporosis: effect of fat mass on the
determination of osteoporosis. J Bone Miner Res 2008, 23:17–29.
21. Baz-Hecht M, Goldfine AB: The impact of vitamin D deficiency on diabetes
and cardiovascular risk. Curr Opin Endocrinol Diabetes Obes 2010, 17:113–119.
22. Swales HH, Wang TJ: Vitamin D and cardiovascular disease risk: emerging
evidence. Curr Opin Cardiol 2010, 25:513–517.
23. Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, Sikaris K,
Ebeling PR, Daly RM: Low serum 25-hydroxyvitamin D is associated withincreased risk of the development of the metabolic syndrome at five
years: results from a national, population-based prospective study. J Clin
Endocrinol Metab 2012, 97:1953–1961.
24. Maki KC, Fulgoni VL 3rd, Keast DR, Rains TM, Park KM, Rubin MR: Vitamin D
intake and status are associated with lower prevalence of metabolic
syndrome in U.S. Adults: national health and nutrition examination
surveys 2003–2006. Metab Syndr Relat Disord 2012, 10:363–372.
25. Sauque-Reyna L, Salcedo-Parra MA, Sánchez-Vargas PR, Flores-Helguera JD,
Badillo-Sánchez C, Reza-Albarrán A, Rodríguez-Morán M, Guerrero-Romero F:
Bone mineral density in patients with type 2 diabetes. Rev Invest Clin
2011, 63:162–169.
26. Hamann C, Kirschner S, Günther KP, Hofbauer LC: Bone, sweet bone-
osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol 2012, 8:297–305.
27. Jeon YK, Lee JG, Kim SS, Kim BH, Kim YK, Kim IJ: Association between bone
mineral density and metabolic syndrome in pre- and postmenopausal
women. Endocr J 2011, 58:87–93.
28. Buizert PJ, van NM S, Lips P, Deeg DJH, Eekhoff EM: Lipid levels: a link
between cardiovascular disease and osteoporosis? J Bone Miner Res 2009,
24:1103–1109.
29. Arikan DC, Coskun A, Ozer A, Kilinc M, Atalay F, Arikan T: Plasma selenium,
zinc, copper and lipid levels in postmenopausal Turkish women and
their relation with osteoporosis. Biol Trace Elem Res 2011, 144:407–417.
30. Von Muhlen D, Safii S, Jassal SK, Svartberg J, Barrett-Connor E: Associations
between the metabolic syndrome and bone health in older men and
women: the rancho bernardo study. Osteoporos Int 2007, 18:1337–1344.
31. Kinjo M, Setoguchi S, Solomon DH: Bone mineral density in adults with
the metabolic syndrome: analysis in a population-based U.S. sample.
J Clin Endocrinol Metab 2007, 92:4161–4164.
32. Shen C, Deng J, Zhou R, Chen J, Fan S, Li Z, Hu Y, Zhong Q: Relation
between bone mineral density, bone loss and the risk of cardiovascular
disease in a Chinese cohort. Am J Cardiol 2012, 110:1138–1142.
33. Ganesan K, Teklehaimanot S, Tran TH, Asuncion M, Norris K: Relationship of
C-reactive protein and bone mineral density in community-dwelling
elderly females. J Natl Med Assoc 2005, 97:329–333.
34. Tao B, Liu JM, Li XY, Wang JG, Wang WQ, Ning G: An assessment of the
use of quantitative ultrasound and the osteoporosis self-assessment tool
for Asians in determining the risk of nonvertebral fracture in postmeno-
pausal Chinese women. J Bone Miner Metab 2008, 26:60–65.
35. Njeh CF, Hans D, Li J, Fan B, Fuerst T, He YQ, Tsuda-Futami E, Lu Y, Wu CY,
Genant HK: Comparison of six calcaneal quantitative ultrasound de-
vices: precision and hip fracture discrimination. Osteoporos Int 2000,
11:1051–1062.
doi:10.1186/1472-6823-14-14
Cite this article as: Sun et al.: Association of calcaneal quantitative
ultrasound parameters with metabolic syndrome in middle-aged and
elderly Chinese: a large population-based cross-sectional study. BMC
Endocrine Disorders 2014 14:14.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
